---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-004449"
form_type: "8-K"
ticker: null
cik: "0001476963"
company_name: "Scorpius Holdings, Inc."
filed_at: "2023-03-23T23:59:59+00:00"
generated_at: "2026-06-17T18:07:09.549675+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NightHawk Biosciences restates Q2 and Q3 2022 financials; net loss overstated

## Summary
- Net loss overstated by ~$3.3M for Q2 2022 and ~$2.9-3.3M for Q3 2022 due to deferred tax asset valuation allowance error from Elusys acquisition.
- Restatement will decrease net loss per share by $0.13 for Q2 and $0.12-$0.13 for Q3.
- Material weakness identified in internal controls over income tax accounting; remediation plan to be described in 2022 10-K.
- Audit committee concluded prior period financials should no longer be relied upon.
- Errors had no effect on cash position, pre-tax loss, or operating expenses.

## SEC filing metadata
- accession: 0001558370-23-004449
- form_type: 8-K
- cik: 0001476963
- company_name: Scorpius Holdings, Inc.
- filed_at: 2023-03-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 4.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1476963/000155837023004449/0001558370-23-004449-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1476963/000155837023004449/nhwk-20230317x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-004449
- JSON: https://secwatch.observer/filing/0001558370-23-004449.json
- Plain text: https://secwatch.observer/filing/0001558370-23-004449.txt

## Key facts
- Auditor Changes
  Scorpius Holdings, Inc. reported that prior financial statements should not be relied upon.
  - Action: non reliance
  - Auditor: BDO USA, LLP
  source text: should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these specified financial statements is required.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1476963/000155837023004449/0001558370-23-004449-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
